These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 23055734)
1. Co-nanoencapsulation of magnetic nanoparticles and selol for breast tumor treatment: in vitro evaluation of cytotoxicity and magnetohyperthermia efficacy. Estevanato LL; Da Silva JR; Falqueiro AM; Mosiniewicz-Szablewska E; Suchocki P; Tedesco AC; Morais PC; Lacava ZG Int J Nanomedicine; 2012; 7():5287-99. PubMed ID: 23055734 [TBL] [Abstract][Full Text] [Related]
2. Combination of selol nanocapsules and magnetic hyperthermia hinders breast tumor growth in aged mice after a short-time treatment. Pinheiro WO; Costa do Santos MS; Farias GR; Fascineli ML; Ramos KLV; Duarte ECB; Damasceno EAM; da Silva JR; Joanitti GA; de Azevedo RB; Sousa MH; Lacava ZGM; Mosiniewicz-Szablewska E; Suchocki P; Morais PC; de Andrade LR Nanotechnology; 2022 Feb; 33(20):. PubMed ID: 35100566 [TBL] [Abstract][Full Text] [Related]
3. Magnetic studies of polylactic- Mosiniewicz-Szablewska E; Tedesco AC; Suchocki P; Morais PC Phys Chem Chem Phys; 2020 Sep; 22(37):21042-21058. PubMed ID: 32926060 [TBL] [Abstract][Full Text] [Related]
5. Decoration of a Poly(methyl vinyl ether-co-maleic anhydride)-Shelled Selol Nanocapsule with Folic Acid Increases Its Activity Against Different Cancer Cell Lines Ganassin R; Souza LR; Py-Daniel KR; Longo JPF; Coelho JM; Rodrigues MC; Jiang CS; Gu J; Morais PC; Mosiniewicz-Szablewska E; Suchocki P; Báo SN; Azevedo RB; Muehlmann LA J Nanosci Nanotechnol; 2018 Jan; 18(1):522-528. PubMed ID: 29768877 [TBL] [Abstract][Full Text] [Related]
6. Nanocapsules for the co-delivery of selol and doxorubicin to breast adenocarcinoma 4T1 cells in vitro. Ganassin R; Merker C; Rodrigues MC; Guimarães NF; Sodré CSC; Ferreira QDS; da Silva SW; Ombredane AS; Joanitti GA; Py-Daniel KR; Zhang J; Jiang CS; de Morais PC; Mosiniewicz-Szablewska E; Suchocki P; Longo JPF; Meijer J; Estrela-Lopis I; de Azevedo RB; Muehlmann LA Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):2002-2012. PubMed ID: 29179603 [TBL] [Abstract][Full Text] [Related]
7. Bacterial exopolysaccharide based magnetic nanoparticles: a versatile nanotool for cancer cell imaging, targeted drug delivery and synergistic effect of drug and hyperthermia mediated cancer therapy. Sivakumar B; Aswathy RG; Sreejith R; Nagaoka Y; Iwai S; Suzuki M; Fukuda T; Hasumura T; Yoshida Y; Maekawa T; Sakthikumar DN J Biomed Nanotechnol; 2014 Jun; 10(6):885-99. PubMed ID: 24749386 [TBL] [Abstract][Full Text] [Related]
8. Synergistic Antitumor Efficacy of Magnetohyperthermia and Poly(lactic-co-glycolic acid)-Encapsulated Selol in Ehrlich Breast Adenocarcinoma Treatment in Elderly Swiss Mice. Pinheiro WO; Fascineli ML; Ramos KLV; de Andrade LR; Farias GR; Neta MSB; Corrêa LH; Duarte ECB; Damasceno EAM; Magalhães KG; da Silva JR; Azevedo RB; Sousa MH; Lacava ZGM J Biomed Nanotechnol; 2020 Feb; 16(2):179-192. PubMed ID: 32252879 [TBL] [Abstract][Full Text] [Related]
9. Dual pH and temperature stimuli-responsive magnetic nanohydrogels for thermo-chemotherapy. Jaiswal MK; Pradhan A; Banerjee R; Bahadur D J Nanosci Nanotechnol; 2014 Jun; 14(6):4082-9. PubMed ID: 24738355 [TBL] [Abstract][Full Text] [Related]
10. Dual-responsive polymer coated superparamagnetic nanoparticle for targeted drug delivery and hyperthermia treatment. Patra S; Roy E; Karfa P; Kumar S; Madhuri R; Sharma PK ACS Appl Mater Interfaces; 2015 May; 7(17):9235-46. PubMed ID: 25893447 [TBL] [Abstract][Full Text] [Related]
12. Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy. Carneiro ML; Nunes ES; Peixoto RC; Oliveira RG; Lourenço LH; da Silva IC; Simioni AR; Tedesco AC; de Souza AR; Lacava ZG; Báo SN J Nanobiotechnology; 2011 Mar; 9():11. PubMed ID: 21443799 [TBL] [Abstract][Full Text] [Related]
13. A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft model. Shakeri-Zadeh A; Shiran MB; Khoee S; Sharifi AM; Ghaznavi H; Khoei S J Biomater Appl; 2014 Oct; 29(4):548-56. PubMed ID: 24913615 [TBL] [Abstract][Full Text] [Related]
14. A novel magnetic nanoparticle hyperthermia combined with ACMF-dependant drug release by DAMMs injection in VX-2 liver tumors. Zhang Q; Tong J; Chen H; Jiang L; Zhu H; Zhu X; Yu H; Liu J; Liu B J Nanosci Nanotechnol; 2012 Jan; 12(1):127-31. PubMed ID: 22523955 [TBL] [Abstract][Full Text] [Related]
15. Multifunctional magnetic nanoparticles for synergistic enhancement of cancer treatment by combinatorial radio frequency thermolysis and drug delivery. Xu Y; Karmakar A; Heberlein WE; Mustafa T; Biris AR; Biris AS Adv Healthc Mater; 2012 Jul; 1(4):493-501. PubMed ID: 23184783 [TBL] [Abstract][Full Text] [Related]
16. Antitumoral Drug: Loaded Hybrid Nanocapsules Based on Chitosan with Potential Effects in Breast Cancer Therapy. Dellali KZ; Rata DM; Popa M; Djennad M; Ouagued A; Gherghel D Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784525 [TBL] [Abstract][Full Text] [Related]
17. Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo. Klippstein R; Wang JT; El-Gogary RI; Bai J; Mustafa F; Rubio N; Bansal S; Al-Jamal WT; Al-Jamal KT Small; 2015 Sep; 11(36):4704-22. PubMed ID: 26140363 [TBL] [Abstract][Full Text] [Related]
18. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy. Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955 [TBL] [Abstract][Full Text] [Related]
19. Breast cancer suppression by curcumin-naringenin-magnetic-nano-particles: In vitro and in vivo studies. Askar MA; El Shawi OE; Abou Zaid OAR; Mansour NA; Hanafy AM Tumour Biol; 2021; 43(1):225-247. PubMed ID: 34542050 [TBL] [Abstract][Full Text] [Related]
20. Selol nanocapsules with a poly(methyl vinyl ether-co-maleic anhydride) shell conjugated to doxorubicin for combinatorial chemotherapy against murine breast adenocarcinoma in vivo. Ganassin R; Horst FH; Camargo NS; Chaves SB; Morais PC; Mosiniewicz-Szablewska E; Suchocki P; Figueiró Longo JP; Azevedo RB; Muehlmann LA Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1046-1052. PubMed ID: 29842818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]